ENLIVEN THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.99 USD | -2.61% |
|
+5.06% | +58.89% |
| Jun. 11 | Baird Initiates Enliven Therapeutics With Outperform Rating, $32 Price Target | MT |
| May. 29 | Enliven Therapeutics, Inc. Appoints Lori Kunkel to the Committee | CI |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-06-06 | 2024-06-07 | 2024-06-10 | 2024-06-11 | |
|---|---|---|---|---|
| Last | 20.2 $ | 20.94 $ | 22.58 $ | 21.99 $ |
| Volume | 107 402 | 196 190 | 199 531 | 185 281 |
| Change | -1.17% | +3.66% | +7.83% | -2.61% |
| Opening | 20.27 | 19.95 | 20.79 | 22.58 |
| High | 20.47 | 21.95 | 22.77 | 22.58 |
| Low | 19.79 | 19.52 | 20.79 | 21.74 |
Performance
| 1 day | -2.61% | ||
| 1 week | +5.06% | ||
| Current month | -2.57% | ||
| 1 month | -6.15% | ||
| 3 months | +63.13% | ||
| 6 months | +102.30% | ||
| Current year | +58.89% | ||
| 1 year | +1.71% |
Volumes
marketsDaily volume
185 281
Estimated daily volume
185 281
Avg. Volume 20 sessions
236 620
Daily volume ratio
0.78
Avg. Volume 20 sessions USD
5 203 273.80
Record volume 1
3 347 739
Record volume 2
3 189 972
Record volume 3
1 091 557
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
1 062 088 640
Net sales (USD)
0
Number of employees
50
Sales / Employee (USD)
0
Free-Float
93.23 %
Free-Float capitalization (USD)
990 132 999
Average Daily Capital Traded
0.49%
Highs and lows
1 week
19.52
22.77
1 month
19.5225.00
Current year
10.9026.00
1 year
9.8026.00
3 years
9.8026.00
5 years
9.8026.00
10 years
9.8026.00
Indicators
Moving average 5 days
21.23
Moving average 20 days
22.59
Moving average 50 days
20.84
Moving average 100 days
18.44
Price spread / (MMA5)
-3.46%
Price spread / (MMA20)
+2.72%
Price spread / (MMA50)
-5.24%
Price spread / (MMA100)
-16.15%
STIM
RSI 9 days
55.74
RSI 14 days
54.35
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -2.61% | +5.06% | +58.89% | +1.71% | 1.06B | ||
| -0.36% | +1.39% | +18.34% | +44.12% | 125B | ||
| +0.88% | +1.74% | +15.06% | +35.37% | 108B | ||
| +0.84% | -0.68% | -6.39% | -9.57% | 23.64B | ||
| +0.31% | +0.69% | +2.39% | -3.51% | 22.39B | ||
| -1.48% | -2.25% | -12.11% | -29.22% | 17.78B | ||
| +0.17% | -1.89% | -41.64% | -37.04% | 16.43B | ||
| +1.61% | +2.26% | -12.07% | -26.59% | 16.34B | ||
| -1.15% | -0.25% | +1.05% | +42.57% | 13.56B | ||
| -0.99% | +1.39% | +25.87% | -4.93% | 11.59B | ||
| +3.29% | +8.54% | +99.65% | +212.47% | 9.66B | ||
| -2.83% | +7.04% | -26.46% | -34.56% | 8.3B | ||
| +0.97% | +2.31% | +15.57% | +43.55% | 7.82B | ||
| +0.34% | -1.88% | +4.75% | +42.38% | 7.54B | ||
| +0.02% | -0.91% | -5.00% | +22.69% | 7.34B | ||
| -2.42% | +12.69% | +35.06% | +47.00% | 6.51B | ||
| Average | -0.21% | +2.24% | +10.81% | +21.65% | ||
| Weighted average by Cap. | +0.13% | +1.43% | +10.40% | +27.01% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
c864634c4a7bff68ad194f.lTSchDkX_bKrRxqNDnxOP_0l1fliWYKOXWzihMrVHyU.3HPo02BVv8v_HkzSfjUARbsIgYo2FtLJORyA7ICSeVTYBKjbWGSy58oocQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 21.99 | 19,430 | 95,549 |
| 03:59:59 pm | 22 | 100 | 76,119 |
| 03:59:59 pm | 22 | 100 | 76,019 |
| 03:59:59 pm | 22 | 100 | 75,919 |
| 03:59:55 pm | 21.99 | 100 | 75,819 |
| 03:59:55 pm | 21.99 | 100 | 75,719 |
| 03:59:54 pm | 22.02 | 100 | 75,619 |
| 03:59:54 pm | 21.99 | 296 | 75,519 |
| 03:59:53 pm | 21.99 | 100 | 75,223 |
| 03:59:50 pm | 21.96 | 100 | 75,123 |
Monthly variations
Annual change
| 2024 | +58.89% | ||
| 2023 | -41.73% |
- Stock Market
- Equities
- ELVN Stock
- Quotes Enliven Therapeutics, Inc.
